FeesSafety
Pluang+

Pharvaris shows promise with oral HAE drug deucrictibant ahead of 2027 FDA decision.

Analyst Insights
21 Nov 2026, 01:10 WIB
Seeking Alpha
View Source
Bullish
Pharvaris shows promise with oral HAE drug deucrictibant ahead of 2027 FDA decision.

Pharvaris, valued at around $2.25 billion, is focused on its lead drug candidate deucrictibant for hereditary angioedema (HAE). Clinical data shows an 83% reduction in attacks compared to placebo, supporting its potential as an on-demand and prophylactic treatment. The company faces competition from established therapies and generics, along with regulatory and commercialization risks. A key FDA decision is expected by April 23, 2027, which will be crucial for Pharvaris' market prospects.

Pharvaris and its HAE therapy provide context for the health sector's market activity. As of Nov 21, 2026 05:11 WIB, 34 of 150 priced health-sector US stocks on Pluang rose while 115 fell. Notable movers include BFLY at USD 5.41 with a -7.52% change and DNA at USD 7.61 with 92% buy orders and a typical hold time of 10 days.

More News

Globant shares rise 4% as AI-driven services boost investor confidence despite slight revenue dip.

Globant shares rise 4% as AI-driven services boost investor confidence despite slight revenue dip.

Globant's shares rose over 4% following its Q3 results, which showed a slight 1% revenue decline to $611.1 million but met analyst expectations for earnings per share at $1.48. The company's strong adoption of AI, particularly its AI Pods subscriptio...

Company Fundamentals
Bullish
1 hour ago
Propylene oxide market to grow to $24.6B by 2033, driven by polyurethane demand and cleaner production tech

Propylene oxide market to grow to $24.6B by 2033, driven by polyurethane demand and cleaner production tech

The global propylene oxide market is projected to grow from $15.7 billion in 2025 to $24.6 billion by 2033, at a CAGR of 5.95%. Growth is fueled by rising demand for polyurethane materials used in construction, automotive, appliances, and furniture. ...

Market News
Bullish
1 hour ago
Amazon shares drop 4.1% amid AI sell-off and concerns over spending and margins

Amazon shares drop 4.1% amid AI sell-off and concerns over spending and margins

Amazon's stock fell 4.1% to $246.82 following a broad sell-off in AI and mega-cap tech stocks. Investors are concerned about Amazon's high capital spending plans of $220 billion, which have led to free cash outflows despite previously strong cash flo...

Bearish
1 hour ago
Innodata outperforms BigBear.ai with strong revenue growth and profitability in AI data services.

Innodata outperforms BigBear.ai with strong revenue growth and profitability in AI data services.

Innodata and BigBear.ai are two specialized AI companies serving different markets—Innodata focuses on commercial data engineering for tech giants, while BigBear.ai provides decision intelligence for U.S. government and defense. Innodata reported 46....

Market News
Bearish
1 hour ago
S&P 500 enters technical correction as AI stocks plunge, led by Nvidia's 14% drop amid SEC probe rumors.

S&P 500 enters technical correction as AI stocks plunge, led by Nvidia's 14% drop amid SEC probe rumors.

The S&P 500 fell 3.7% to 6,910, entering a technical correction after a seven-day losing streak, while the Nasdaq dropped 5.28%, erasing its annual gains. Nvidia shares plunged 14% following reports of a potential SEC accounting probe, accelerating a...

Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App